The claim is for lower cholesterol and applies to milled or whole flaxseed only.
Health Canada has officially become the first to approve a health claim for flaxseed. The claim is for lower cholesterol and applies to milled or whole flaxseed only. The Flax Council of Canada celebrated the news today, which Nutritional Outlookfirst reported back in December.
The health claim states that daily consumption of 5 tbsp (40 g) of ground flaxseed helps reduce cholesterol levels.
“This is a proud achievement, as Canada is the first country in the world to allow a health-related claim for flaxseed for use on food labels,” said William Hill, president of The Flax Council of Canada (Winnipeg, MB, Canada), in a press release.
The flaxseed health claim is just the tenth health claim for foods and supplements approved by Health Canada. “This claim is one of only a dozen deemed to meet the rigorous scientific criteria established by Health Canada,” Hill said.
“Now food manufacturers will be able to clearly state on labels the relationship between flax consumption and a reduction of cholesterol,” said Eric Fridfinnson, Board Chair of the Manitoba Flax Growers Association (Winnipeg, MB, Canada).
Canada is a leading producer of flaxseed.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.